S
Scribeable
PricingEnterpriseGuild
Sign In
  1. Home
  2. /
  3. Compare
  4. /
  5. vs Epic AI Charting
All Comparisons

Scribeable vs Epic AI Charting: A factual comparison, sourced to public sites and announcements.

For a clinician at an organization that runs Epic and has enabled AI Charting, the tool is already in the chart. Scribeable serves a different need: an account the clinician owns, can use with any web-based EHR, and can carry from one job to the next.

120+ clinicians · 2,600+ notes generated — real counters, no composites (scribeable.ai/transparency)

Why Physicians Switch from Epic AI Charting

AI Charting access comes through an organization's Epic installation rather than a standalone clinician account

Pricing for AI Charting is not stated on epic.com as of Jul 2026

Coding, clinical calculator, and quality-measure specifics for AI Charting are not stated on epic.com as of Jul 2026

Native to Epic

Epic launched AI Charting in February 2026. It ships inside Epic, and Epic describes its generative AI as integrated into the EHR. For a clinician whose organization runs Epic and has turned on AI Charting, it is right there in the chart.

Your Account Goes With You

An employer provides access to its Epic installation and to the features it has enabled. That access ends when the job does. A Scribeable account belongs to the clinician, so the templates and setup can move from one employer to the next.

Not Every Clinic Runs Epic

Scribeable works with any web-based EHR through a browser extension. You finish the note, review it, and insert it with one click. That makes it an option for independent clinics, clinicians off Epic, and people who work across more than one EHR.

Note Quality

Same Patient. Same Encounter. Different AI.

See why physicians say Scribeable notes are “actually usable” — with integrated risk scores, billing codes, and clinical reasoning that typical AI scribes simply don’t generate.

Emergency Medicine
62-year-old male presenting with substernal chest pressure, diaphoresis, and exertional dyspnea
Typical AI Scribe

HPI

62 y/o male presents with chest pain for 2 hours. Substernal, pressure-like, radiating to left arm. Associated with diaphoresis and shortness of breath. Pain started while climbing stairs. Patient has history of HTN, DM2, and hyperlipidemia. Takes lisinopril, metformin, and atorvastatin. Denies recent illness or trauma.

Assessment & Plan

1.Chest pain — likely ACS vs GERD
Troponin, BMP, CBC
12-lead EKG
Chest X-ray
ASA 325mg PO
Nitroglycerin 0.4mg SL PRN
Cardiology consult if troponin elevated
2.HTN — continue home medications
3.DM2 — hold metformin, monitor glucose
Not included
—No risk stratification score
—No dangerous diagnosis exclusion
—No E&M level optimization
—No differential reasoning documented
Scribeable
AI-Enhanced

HPI

62 y/o male presents with 2 hours of substernal chest pressure, rated 8/10, radiating to left arm and jaw. Onset during exertion (climbing stairs). Associated with diaphoresis and exertional dyspnea. Pressure-like quality, unrelieved by rest. No pleuritic component, no positional variation, no reproducibility with palpation. Risk factors: HTN (10 years), DM2 (8 years), hyperlipidemia, 30-pack-year smoking history (quit 5 years ago), family history of MI (father at age 58). Current medications: lisinopril 20mg daily, metformin 1000mg BID, atorvastatin 40mg daily. Denies cocaine use, recent immobilization, or prior VTE.

Structured Risk Factors

Assessment & Plan

1.Acute Chest Pain — High-risk presentation
HEART Score: 7 (High Risk)
History: moderately suspicious (2), EKG: non-specific ST changes (1), Age: >65 (2), Risk factors: ≥3 (2), Troponin: pending initial (0)
Risk stratification: >12% 6-week MACE event rate → full ACS workup
Serial troponins q3h, 12-lead EKG (initial + repeat at 60 min)
ASA 325mg PO administered, heparin drip per ACS protocol
Cardiology consulted for probable cath lab activation
Dangerous Diagnosis Exclusion
STEMI: No ST elevation on initial EKG — serial monitoring
Aortic dissection: No tearing quality, no pulse differential, no mediastinal widening on CXR
PE: Low pretest probability (Wells PE: 1.5) — no immobilization, no prior VTE, no hemoptysis
2.Hypertension — BP 168/94 on arrival, improved to 142/88 post-NTG
Continue home lisinopril, recheck prior to disposition
3.DM2 — Glucose 186 on arrival
Hold metformin (contrast exposure risk), sliding scale insulin PRN
HEART Score: 7 (High Risk)Wells PE: 1.5 (Low Risk)Dangerous Dx ExclusionE&M: 99285 — MDM High
Scribeable
AI-Enhanced

HPI

62 y/o male presents with 2 hours of substernal chest pressure, rated 8/10, radiating to left arm and jaw. Onset during exertion (climbing stairs). Associated with diaphoresis and exertional dyspnea. Pressure-like quality, unrelieved by rest. No pleuritic component, no positional variation, no reproducibility with palpation. Risk factors: HTN (10 years), DM2 (8 years), hyperlipidemia, 30-pack-year smoking history (quit 5 years ago), family history of MI (father at age 58). Current medications: lisinopril 20mg daily, metformin 1000mg BID, atorvastatin 40mg daily. Denies cocaine use, recent immobilization, or prior VTE.

Structured Risk Factors

Assessment & Plan

1.Acute Chest Pain — High-risk presentation
HEART Score: 7 (High Risk)
History: moderately suspicious (2), EKG: non-specific ST changes (1), Age: >65 (2), Risk factors: ≥3 (2), Troponin: pending initial (0)
Risk stratification: >12% 6-week MACE event rate → full ACS workup
Serial troponins q3h, 12-lead EKG (initial + repeat at 60 min)
ASA 325mg PO administered, heparin drip per ACS protocol
Cardiology consulted for probable cath lab activation
Dangerous Diagnosis Exclusion
STEMI: No ST elevation on initial EKG — serial monitoring
Aortic dissection: No tearing quality, no pulse differential, no mediastinal widening on CXR
PE: Low pretest probability (Wells PE: 1.5) — no immobilization, no prior VTE, no hemoptysis
2.Hypertension — BP 168/94 on arrival, improved to 142/88 post-NTG
Continue home lisinopril, recheck prior to disposition
3.DM2 — Glucose 186 on arrival
Hold metformin (contrast exposure risk), sliding scale insulin PRN
HEART Score: 7 (High Risk)Wells PE: 1.5 (Low Risk)Dangerous Dx ExclusionE&M: 99285 — MDM High
2Risk Scores Computed
3Dangerous Dx Excluded
99285E&M Level Captured

*Note examples are illustrative representations based on common AI documentation patterns. “Typical AI Scribe” represents composite characteristics of standard tools and does not depict any specific product. Patient scenarios are entirely fictional. Clinical notes should always be reviewed by a licensed provider.

AI Medical Scribe Note Quality Comparison

Scribeable produces clinically enriched notes with integrated risk calculators (HEART Score, CHA₂DS₂-VASc, Wells PE, PHQ-9, Caprini VTE), automated billing code optimization (E&M levels, HCC/RAF capture, CPT codes), dangerous diagnosis exclusion documentation, evidence-based prescribing citations, CMS compliance for operative reports, HEDIS care gap tracking, and MIPS quality measure documentation. Typical AI scribes produce basic notes without these advanced clinical features.

ED Chest Pain: 62-year-old male presenting with substernal chest pressure, diaphoresis, and exertional dyspnea

HPI: 62 y/o male presents with 2 hours of substernal chest pressure, rated 8/10, radiating to left arm and jaw. Onset during exertion (climbing stairs). Associated with diaphoresis and exertional dyspnea. Pressure-like quality, unrelieved by rest. No pleuritic component, no positional variation, no reproducibility with palpation. Risk factors: HTN (10 years), DM2 (8 years), hyperlipidemia, 30-pack-year smoking history (quit 5 years ago), family history of MI (father at age 58). Current medications: lisinopril 20mg daily, metformin 1000mg BID, atorvastatin 40mg daily. Denies cocaine use, recent immobilization, or prior VTE.

Assessment & Plan: 1. Acute Chest Pain — High-risk presentation HEART Score: 7 (High Risk) - History: moderately suspicious (2), EKG: non-specific ST changes (1), Age: >65 (2), Risk factors: ≥3 (2), Troponin: pending initial (0) - Risk stratification: >12% 6-week MACE event rate → full ACS workup - Serial troponins q3h, 12-lead EKG (initial + repeat at 60 min) - ASA 325mg PO administered, heparin drip per ACS protocol - Cardiology consulted for probable cath lab activation Dangerous Diagnosis Exclusion: - STEMI: No ST elevation on initial EKG — serial monitoring - Aortic dissection: No tearing quality, no pulse differential, no mediastinal widening on CXR - PE: Low pretest probability (Wells PE: 1.5) — no immobilization, no prior VTE, no hemoptysis 2. Hypertension — BP 168/94 on arrival, improved to 142/88 post-NTG - Continue home lisinopril, recheck prior to disposition 3. DM2 — Glucose 186 on arrival - Hold metformin (contrast exposure risk), sliding scale insulin PRN

Cardiology Consult: 71-year-old female with new-onset atrial fibrillation and decompensated heart failure

HPI: 71 y/o female with known HFrEF (EF 35% on TTE 6 months ago), HTN, DM2, and CKD Stage 3a (baseline Cr 1.4), consulted for new-onset atrial fibrillation with RVR. Progressive exertional dyspnea (NYHA II → IV over 2 weeks), 3-pillow orthopnea (new), PND, and 4+ pitting edema to knees bilaterally. Weight gain of 8 lbs over 2 weeks. Triggers explored: dietary indiscretion (holiday meals), medication non-adherence (ran out of furosemide 10 days ago). No prior AF history, no palpitations previously. Denies chest pain, syncope, or presyncope.

Assessment & Plan: Reason for Consult: New-onset atrial fibrillation with RVR in setting of acute decompensated HFrEF. Requesting Service: Internal Medicine (Dr. Patel) 1. New-onset Atrial Fibrillation with RVR CHA₂DS₂-VASc Score: 5 (Female sex, age ≥75, HTN, DM, HF) - Stroke risk: 6.7%/year → strong anticoagulation indication - Rate control: avoid diltiazem (negative inotropy in HFrEF) → amiodarone 150mg IV bolus then 1mg/min × 6h - Anticoagulation: apixaban 5mg BID (preferred over warfarin given age + fall risk) - TEE prior to any cardioversion attempt if AF duration uncertain - HAS-BLED: 2 (HTN, age) — acceptable bleeding risk 2. Acute Decompensated Heart Failure (ADHF) NYHA Functional Class: IV (dyspnea at rest) - IV furosemide 80mg BID (2.5× home oral dose), net negative 1-1.5L/day - Carvedilol held (acute decompensation), restart when euvolemic - Add sacubitril/valsartan when stable (PARADIGM-HF indication: EF ≤40% on ACEi) - BNP trend: 1,840 → monitor for response to diuresis 3. CKD Stage 3a — Cr 1.4 (baseline), monitor with aggressive diuresis - KDIGO risk: moderate — monitor Cr/K daily with diuresis

Operative Note: Right total knee arthroplasty in 68-year-old male with severe tricompartmental osteoarthritis

Operative Note: Preoperative Diagnosis: Right knee severe tricompartmental osteoarthritis (Kellgren-Lawrence Grade IV) Postoperative Diagnosis: Same Procedure: Right total knee arthroplasty Surgeon: Dr. James Morrison (attending — present and scrubbed for entire case) Assistant: Dr. Chen (PGY-4) Anesthesia: Spinal with sedation (Dr. Rivera) Implants: Smith & Nephew Legion CR, Size 5 femoral / Size 4 tibial / 10mm poly insert EBL: 150 mL Tourniquet Time: 62 minutes (pneumatic, 275 mmHg) Specimens: Femoral and tibial bone cuts — to pathology Complications: None Findings: Severe tricompartmental degenerative changes with exposed subchondral bone medially, grade III chondromalacia laterally, intact PCL

Post-Operative Plan: 1. Weight Bearing: WBAT right LE with front-wheeled walker 2. DVT Prophylaxis: Enoxaparin 40mg SQ daily × 14 days + mechanical (SCDs while inpatient) 3. Pain: Multimodal — scheduled acetaminophen 1g Q6h, meloxicam 15mg daily, tramadol 50mg Q6h PRN (max 14 days) 4. Antibiotics: Ancef 2g IV × 24h post-op 5. PT: Initiate POD0 PM — CPM machine, active/passive ROM, gait training 6. Follow-up: 2 weeks (staple removal + wound check), 6 weeks (X-ray + ROM assessment) 7. VTE Risk: Caprini Score 7 (High Risk) — extended pharmacologic prophylaxis indicated

Primary Care: 55-year-old female Medicare Advantage patient with DM2, HTN, depression, and overdue preventive care

HPI: 55 y/o female Medicare Advantage patient presenting for chronic disease management follow-up. Last visit 3 months ago. Diabetes (DM2, 8 years): A1c 8.2% (up from 7.6%), reports adherence but dietary indiscretion during holidays. Home glucose logs show fasting 140-180 range. No hypoglycemic episodes. Denies polyuria, polydipsia, vision changes, or foot numbness. Last diabetic eye exam: 14 months ago (overdue). Last podiatry visit: never. Hypertension (12 years): Home BP readings averaging 135-145/85-90. Taking lisinopril 20mg daily consistently. Depression (MDD, recurrent): PHQ-9 score today: 14 (moderately severe). Persistent low mood, anhedonia, poor sleep (initial insomnia), decreased concentration. On sertraline 50mg × 6 months with partial response. Denies SI/HI, denies alcohol or substance use. Columbia Suicide Severity: negative for ideation and behavior.

Assessment & Plan: 1. DM2, Uncontrolled (A1c 8.2%) — HCC 19 - Add empagliflozin 10mg daily (SGLT2i — CV and renal benefit, EMPA-REG OUTCOME indication) - Continue metformin 500mg BID (not escalating given GI intolerance history) - Diabetic eye exam referral (overdue 2 months — HEDIS measure) - Podiatry referral for initial foot exam - Recheck A1c in 3 months, target <7% 2. Hypertension, Suboptimally Controlled — HCC (when with CKD/DM) - BP today 138/86 — above target of <130/80 (ACC/AHA for DM patients) - Increase lisinopril to 40mg daily - Home BP log review in 4 weeks 3. Major Depressive Disorder, Recurrent, Moderate — HCC 59 - PHQ-9: 14 (moderately severe) — partial response to sertraline 50mg - Increase sertraline to 100mg daily - Safety plan reviewed, crisis line provided (988) - Follow-up in 4 weeks, recheck PHQ-9 - If inadequate response → consider augmentation or psychiatry referral 4. Preventive Care Gaps Addressed: - Mammogram ordered (last: 26 months ago — HEDIS BCS measure) - Colonoscopy referral (age 55, average risk, never screened — HEDIS COL) - Tobacco screening: former smoker, quit 3 years — MIPS measure 226 - Annual flu vaccine administered today — MIPS measure 110

Feature-by-Feature Comparison

Access & Portability

FeatureScribeableEpic AI Charting
Available as a standalone clinician accountAI Charting is a feature inside an organization's Epic installation. Scribeable is a clinician-owned account independent of an employer contract.
Works across web-based EHRsEpic describes its generative AI as integrated into the Epic EHR. Scribeable inserts the finished note into any web-based EHR through its browser extension.
Account moves with the clinician across employersAccess to an employer's Epic and its enabled features ends with that job. A Scribeable account belongs to the clinician and moves with them.
Published individual pricingNot stated on epic.com as of Jul 2026

Clinical Intelligence

FeatureScribeableEpic AI Charting
ICD-10, HCC V28, and E&M supportNot stated on epic.com as of Jul 2026
MIPS quality measures scored in the noteNot stated on epic.com as of Jul 2026
Clinical calculators (236, code-scored)Not stated on epic.com as of Jul 2026

Product Structure

FeatureScribeableEpic AI Charting
Documentation AI native to EpicEpic describes generative AI as integrated into its EHR. For organizations on Epic that have enabled AI Charting, it is available in the chart.
Individual access outside an organizational deploymentNot stated on epic.com as of Jul 2026

Competitor facts on this page are sourced to each company's own public site and verified as of 2026-07-17; see page source for the full citation list. Competitor capabilities and pricing may change after that date.

See What You're Missing

Start your 14-day free trial — no credit card required.

Pricing Comparison

Scribeable

Free tier, then $39-79/month, published

Start free, upgrade when ready. No contracts.

Epic AI Charting

Not publicly stated on the reviewed Epic AI page

Contact for pricing

Scribeable publishes individual pricing. Pricing for Epic AI Charting is not stated on epic.com as of Jul 2026.

Scott Kohlhepp, DO, founder of Scribeable

Built and owned by a practicing physician

Scott Kohlhepp, DO

Why I built this · Security and BAA

Other AI scribes optimize for time to first draft. Scribeable optimizes for time to signed note, with a verification pass built in before you sign.

5.0 on the App Store

120+

Clinicians on board

2,600+

Patient notes generated

Which Should You Choose?

Choose Scribeable if you...

  • Independent clinicians and clinics that do not run Epic
  • Employed clinicians who want an account that moves with them across jobs
  • Clinicians who work in more than one web-based EHR

Choose Epic AI Charting if you...

  • Clinicians at organizations that run Epic and have enabled AI Charting
  • Health systems that want documentation AI native to their EHR
  • Clinicians who prefer to use a documentation feature already inside their employer's Epic chart

Frequently Asked Questions

Compare Other Alternatives

vs Dragon Copilot

Considering Microsoft Dragon Copilot, the product formerly sold as Nuance DAX? Here is a factual look at how Scribeable differs — on pricing transparency, who owns the account, and who each company answers to.

Compare

vs Nabla

Considering Nabla? Here is a factual look at how Scribeable differs — on pricing transparency, who owns the account, and the capital structure behind the "we don't train on your data" promise both companies make.

Compare

vs Abridge

Considering Abridge? Here is a factual look at how Scribeable differs — on pricing transparency, who owns the account, and the capital structure behind the platform.

Compare

Start Your 14-Day Free Trial — No Credit Card

Compare Scribeable to Epic AI Charting on your own terms. Generate your first note in under 5 minutes.

Scribeable vs Epic AI Charting - AI Medical Scribe Comparison

For a clinician at an organization that runs Epic and has enabled AI Charting, the tool is already in the chart. Scribeable serves a different need: an account the clinician owns, can use with any web-based EHR, and can carry from one job to the next.

Why Physicians Switch from Epic AI Charting

  • AI Charting access comes through an organization's Epic installation rather than a standalone clinician account
  • Pricing for AI Charting is not stated on epic.com as of Jul 2026
  • Coding, clinical calculator, and quality-measure specifics for AI Charting are not stated on epic.com as of Jul 2026

Why Choose Scribeable Over Epic AI Charting

  • Clinician-owned account that moves with you across employers
  • Works with any web-based EHR through a browser extension that inserts the finished note with one click
  • Published self-serve pricing: Lite $39/month and Pro $79/month
  • Coding engine with ICD-10, HCC V28, and E&M support included at Pro
  • MIPS quality measures and 236 code-scored clinical calculators inside the note
  • A two-stage AI pipeline with a separate verification pass that asks a clarification question instead of guessing

Native to Epic

Epic launched AI Charting in February 2026. It ships inside Epic, and Epic describes its generative AI as integrated into the EHR. For a clinician whose organization runs Epic and has turned on AI Charting, it is right there in the chart.

Your Account Goes With You

An employer provides access to its Epic installation and to the features it has enabled. That access ends when the job does. A Scribeable account belongs to the clinician, so the templates and setup can move from one employer to the next.

Not Every Clinic Runs Epic

Scribeable works with any web-based EHR through a browser extension. You finish the note, review it, and insert it with one click. That makes it an option for independent clinics, clinicians off Epic, and people who work across more than one EHR.

Feature Comparison: Scribeable vs Epic AI Charting

Access & Portability

FeatureScribeableEpic AI Charting
Available as a standalone clinician accountYesNo
Works across web-based EHRsYesNo
Account moves with the clinician across employersYesNo
Published individual pricingYesPartial

Clinical Intelligence

FeatureScribeableEpic AI Charting
ICD-10, HCC V28, and E&M supportYesPartial
MIPS quality measures scored in the noteYesPartial
Clinical calculators (236, code-scored)YesPartial

Product Structure

FeatureScribeableEpic AI Charting
Documentation AI native to EpicNoYes
Individual access outside an organizational deploymentYesPartial

Pricing Comparison

Scribeable: Free tier, then $39-79/month, published

Epic AI Charting: Not publicly stated on the reviewed Epic AI page

Scribeable publishes individual pricing. Pricing for Epic AI Charting is not stated on epic.com as of Jul 2026.

Which Should You Choose?

If your organization runs Epic and has enabled AI Charting, using the documentation tool already inside the chart can make sense. If you work outside Epic, move between employers, or want an account that belongs to you, Scribeable works with any web-based EHR and goes with you.

Frequently Asked Questions

Can I use Scribeable if my hospital uses Epic?

Yes. Your Scribeable account is independent of the hospital contract, and the browser extension inserts the finished note into any web-based EHR, including Epic.

Is Epic AI Charting a standalone product?

No. AI Charting is a feature of the Epic EHR. Clinicians get it through an organization's Epic installation when that organization has enabled it.

What does Epic AI Charting cost?

Pricing is not stated on Epic's public AI page as of Jul 2026. Scribeable publishes Lite at $39/month and Pro at $79/month, with a free tier of 5 notes each month after the trial.

Does Epic AI Charting include coding and clinical calculators?

Coding specifics, clinical calculators, and quality measures for AI Charting are not stated on epic.com as of Jul 2026. Scribeable Pro includes ICD-10, HCC V28, E&M support, MIPS measures, and 236 code-scored calculators.

Compare Other AI Medical Scribes

  • Scribeable vs Dragon Copilot
  • Scribeable vs Nabla
  • Scribeable vs Abridge

Sources

Epic launched AI Charting, its EHR-native ambient documentation feature, in February 2026.

Epic describes generative AI as integrating into the Epic EHR. Its public AI page does not state pricing, standalone individual access, coding specifics, clinical calculators, or quality measures for AI Charting.

Scribeable pricing: Lite $39/mo, Pro $79/mo.

Explore More

Discover how Scribeable can help your practice with AI-powered clinical documentation

📚

Blog & Resources

Insights on clinical documentation, AI in healthcare, burnout prevention, and productivity tips.

🩺

Medical Conditions

ICD-10 documentation guides for hypertension, diabetes, COPD, and 100+ conditions.

👨‍⚕️

Specialties

AI documentation tailored for 18+ medical specialties from cardiology to psychiatry.

🔗

EHR Integrations

Works with Epic, Cerner, athenahealth, and other major EHR systems.

Specialties

  • Internal Medicine
  • Emergency Medicine
  • Primary Care
  • Cardiology
  • View all →

Compare

  • vs Dragon Copilot
  • vs DeepScribe
  • vs Abridge
  • vs Suki
  • View all →

Clinical Content

  • Medical Conditions
  • Hypertension
  • Type 2 Diabetes
  • CPT Codes
  • EHR Integrations
  • Locations by State

Resources

  • Documentation
  • Blog
  • FAQ
  • Security & HIPAA
  • Support

Getting Started

  • Pricing
  • Download App
  • ROI Calculator
  • Contact Sales
S
Scribeable
ComparePricingSpecialtiesContact

© 2026 Scribeable LLC All rights reserved.